Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Deoxycytidine Kinase (DCK) Peptide

DCK Reactivité: Mammifères Hôte: Synthetic BP, WB, IHC
N° du produit ABIN936955

Aperçu rapide pour Deoxycytidine Kinase (DCK) Peptide (ABIN936955)

Antigène

DCK (Deoxycytidine Kinase (DCK))

Origine

Mammifères

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
  • Type de proteíne

    Synthetic

    Séquence

    ATPETCLHRI YLRGRNEEQG IPLEYLEKLH YKHESWLLHR TLKTNFDYLQ

    Attributs du produit

    A synthetic peptide for use as a blocking control in assays to test for specificity of DCK antibody,
    Alternative Names: DCK control peptide, DCK antibody Blocking Peptide, Anti-DCK Blocking Peptide, Deoxycytidine Kinase Blocking Peptide, MGC117410 Blocking Peptide, MGC138632 Blocking Peptide
  • Indications d'application

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20 °C long term.
  • Antigène

    DCK (Deoxycytidine Kinase (DCK))

    Sujet

    Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.

    Poids moléculaire

    30 kDa
Vous êtes ici:
Chat with us!